Loading clinical trials...
Loading clinical trials...
This is a multi-center, observational, single-arm, 6-week home study to evaluate the safety and efficacy of transcutaneous spinal cord stimulation via the ExaStim system for 4 consecutive weeks used in the home setting for individuals with traumatic spinal cord injury. The study consists of a baseline evaluation and 1-week training period (Week 0), a 4-week stimulation period (Weeks 1-4), and a follow-up visit (Week 5), for a total expected duration of participation for each subject of six weeks.
During the first week of the study, baseline measurements will be recorded for each subject and all eligible subjects and their caregivers will participate in a 1-week "Training Phase." Subsequently, subjects will perform activities of daily living and/or home exercises in conjunction with the ExaStim over a 4-week period in the home setting. In each session, subjects will receive stimulation while performing therapist-prescribed home exercises or activities of daily living. Stimulation must be utilized for a maximum of 300 -minutes per week and a minimum of 125-minutes per week. The time spent using stimulation during home sessions, and the number of sessions that patients perform each week, is flexible and is intended to facilitate the use of ExaStim within each participant's daily routine. Subjects and Clinicians will participate in weekly telehealth check-ins throughout the 4-week period in the home setting and will return to the clinic within one week of the final treatment to complete the final assessments in the study.
Age
22 - No limit years
Sex
ALL
Healthy Volunteers
No
Craig Rehabilitation Hospital
Denver, Colorado, United States
TryAbility Neurorecovery Center
Downer Grove, Illinois, United States
Internation Center for Spinal Cord Injury at the Kennedy Krieger Institute
Baltimore, Maryland, United States
Spaulding Rehabilitation Hospital
Boston, Massachusetts, United States
Marquette University Neuro Recovery Clinic
Milwaukee, Wisconsin, United States
Start Date
March 17, 2025
Primary Completion Date
October 30, 2025
Completion Date
October 30, 2025
Last Updated
June 24, 2025
30
ESTIMATED participants
ExaStim Stimulation System
DEVICE
Lead Sponsor
Niche Biomedical, Inc. dba ANEUVO
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07127172